Home › Grants › United States

Funding programs in United States

Hand-checked programs plus official open data. Each links to its official page. Loans and private funders are labelled.

United States grant list United States funders United States student funding guide

Open-data catalog: Research and science

Human Genome Research - Research Projects (Assistance Listing 93.HG1) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Human Genome Research - Small Business (Assistance Listing 93.HG6) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Human Genome Research - Training, Individual (Assistance Listing 93.HG5) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Human Genome Research - Training, Institutional (Assistance Listing 93.HG4) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Human Genome Research (Assistance Listing 93.172) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Human Virome Program: Developing novel and innovative tools to interrogate and annotate the human virome (U01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
IDeA Networks of Biomedical Research Excellence (INBRE) · National Institutes of Health · United States (federal) · Forecast
IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed) · National Institutes of Health · United States (federal) · Closes 14 December 2026
Illuminating AD/ADRD Genome to Enable Precision Genomic Medicine · National Institutes of Health · United States (federal) · Forecast
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Immune Tolerance Network (UM1 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 29 January 2027
Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Impact of Immunotherapies on CNS Outcomes in People with HIV: Potential Benefits, Challenges and Risks · National Institutes of Health · United States (federal) · Forecast
Impact of Initial Influenza Exposure on Immunity in Infants (U01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Implementation and Evaluation of Databases to Examine AIDS · National Institutes of Health · United States (federal) · Forecast
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 20 June 2029
Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Improving Chronic Conditions Through Inexpensive Interventions · National Institutes of Health · United States (federal) · Forecast
In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 15 June 2028
INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 15 June 2028
INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Forecast
INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 15 June 2028
Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 7 May 2027
Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 7 May 2027
Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) (U01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 10 November 2026
Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Infrastructure for Population Dynamics Research Program (iPOP) · National Institutes of Health · United States (federal) · Forecast
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 20 October 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 20 October 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 20 October 2027
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) · National Institutes of Health · United States (federal) · Closes 7 January 2028
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 7 January 2028
Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes (R34 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 16 November 2027
Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed) · National Institutes of Health · United States (federal) · Closes 12 July 2029
Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 26 May 2028
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Forecast
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 10 September 2027
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 January 2028
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Interdisciplinary Research Networks to Advance Biomedical Research on Resilience and Health Optimization · National Institutes of Health · United States (federal) · Forecast
Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimer’s and Related Dementias Disease Risk · National Institutes of Health · United States (federal) · Forecast
International Research and Research Training (Assistance Listing 93.989) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
International Research Scientist Development Award (IRSDA) · National Institutes of Health · United States (federal) · Forecast
International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Intervention Research to Improve Native American Health · National Institutes of Health · United States (federal) · Forecast
Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 January 2027
Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional) · National Institutes of Health · United States (federal) · Closes 7 January 2028
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 7 January 2027
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) · National Institutes of Health · United States (federal) · Closes 7 September 2027
Intramural - Extramural Collaboration for Advanced 3-D Tissue Models for Drug Screening (Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Forecast
Intramural Research Training Award (Assistance Listing 93.140) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Forecast
Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01 - Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (Assistance Listing 93.T21) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 17 November 2026
Investigator-Focused Award (Parent R35) · National Institutes of Health · United States (federal) · Forecast
Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
KUH P30 Resource Core Center (P30 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Forecast
KUH U24 Center Coordinating Hub (U24 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Forecast
Laboratories to Optimize Digital Health (R01 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 7 January 2028
Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 July 2028
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
LAUNCHing Leaders for Future U.S. Investments in Global Health Research (D43 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
Learning Disabilities Research Centers · National Institutes of Health · United States (federal) · Forecast
Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 15 November 2027
LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE) · National Institutes of Health · United States (federal) · Forecast
Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 6 November 2026
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24 Clinical Trials Optional) · National Institutes of Health · United States (federal) · Forecast
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24 Clinical Trials Optional) · National Institutes of Health · United States (federal) · Forecast
Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Limited Competition: Biomedical Research Environment & Sponsored Programs Administration Development (BRE-SPAD) Program · National Institutes of Health · United States (federal) · Forecast
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET · National Institutes of Health · United States (federal) · Closes 11 February 2027
Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships · National Institutes of Health · United States (federal) · Forecast
Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 7 January 2028
Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 26 May 2029
Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 25 May 2029
Limited Competition: Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium- Field Epidemiology Sites · National Institutes of Health · United States (federal) · Forecast
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 19 October 2027

Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.